High vs Normal Protein Diets, Resistance Exercise, Lean Mass and Strength Gains

January 17, 2017 updated by: Erick Prado de Oliveira, Federal University of Uberlandia

Effect of Normal and High Protein Diets in Lean Mass, Adiposity, and Strength in Postmenopausal Women Practitioners of Resistance Exercise

This study evaluates the effect of different types of diets (high and normal protein) on lean and fat mass, and strength in postmenopausal women practitioners of resistance exercise. Two groups will be created: high protein (1.2 protein g/body mass/day) and normal protein (0.8 protein g/body mass/day). The same training will be performed for both groups.

Study Overview

Status

Unknown

Conditions

Detailed Description

Both groups will undergo the same training protocol, differing only on the protein content of the diet. The dietary assessment will be made through the 24-hour food recall, being conducted at the beginning, middle and end of the intervention. Resistance exercises for upper and lower limbs will be performed, at 70% of one repetition maximum. SPPB, tug, 6-minutes and 400 meters will be performed.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women in the postmenopausal period (menopausal for at least one year, confirmed by laboratory diagnostic tests menopause - LH and high FSH and estradiol decreased);
  • Healthy;
  • Who agree to participate and sign the consent term.

Exclusion Criteria:

  • The one who does not provide the necessary information for the development of the study;
  • Present orthopedic limitations;
  • Patients with previously diagnosed and treatment of diseases such as type II diabetes mellitus, hypertension and cardiovascular disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High protein diet (HP)
Diet with 1.2 protein g/kg body mass/day for postmenopausal women practitioners of resistance exercise. The physical strength training will be performed equally by both groups
To observe the effect of a high protein (HP) diet over muscle mass, fat mass, and strength changes, focusing in differences between the NP and HP groups.
The physical strength training will be performed equally by both groups, containing exercises for upper and lower limbs and aiming for hypertrophy.
Placebo Comparator: Normal protein diet (NP)
Diet with 0.8 protein g/kg body mass/day for postmenopausal women practitioners of resistance exercise. The physical strength training will be performed equally by both groups
The physical strength training will be performed equally by both groups, containing exercises for upper and lower limbs and aiming for hypertrophy.
To observe the effect of a normal protein (NP) diet over muscle mass, fat mass, and strength changes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in the lean mass of postmenopausal women practicing strength exercise
Time Frame: Before and immediately after the intervention (initial moment and 10 weeks after start of the intervention)
Before and immediately after the intervention (initial moment and 10 weeks after start of the intervention)

Secondary Outcome Measures

Outcome Measure
Time Frame
Changes in the fat mass of postmenopausal women practicing strength exercise
Time Frame: Before and immediately after the intervention (initial moment and 10 weeks after start of the intervention)
Before and immediately after the intervention (initial moment and 10 weeks after start of the intervention)
Changes on strength of postmenopausal women practicing strength exercise
Time Frame: Before and immediately after the intervention (initial moment and 10 weeks after start of the intervention)
Before and immediately after the intervention (initial moment and 10 weeks after start of the intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erick P de Oliveira, PhD, Federal University of Uberlândia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Actual)

August 1, 2016

Study Completion (Anticipated)

February 1, 2017

Study Registration Dates

First Submitted

October 31, 2016

First Submitted That Met QC Criteria

January 17, 2017

First Posted (Estimate)

January 18, 2017

Study Record Updates

Last Update Posted (Estimate)

January 18, 2017

Last Update Submitted That Met QC Criteria

January 17, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Clinical Trials on High protein

Subscribe